+ Share options
Drug discovery for rare diseases
Be an early applicant
Drug discovery for rare diseases
101-200 employees
Be an early applicant
+ Share options
101-200 employees
Healx's mission is to pioneer the next generation of drug discovery in order to bring novel, effective treatments to rare disease patients around the world.
There are 7,000 known rare diseases around the world, and only 5% of them have an approved treatment. Healx solves this problem by leveraging AI to develop and identify drug treatments for rare conditions.
Healx's platform, Healnet, uses machine learning to find connections between rare diseases and existing drugs. Repurposing drugs is more time and cost effective than developing new treatments, and therefore has broad appeal within the pharma community.
At the moment, the company is focused on rare conditions such as Fragile X syndrome, but they are looking to rapidly expand their scope to other diseases.

Freddie
Company Specialist at Welcome to the Jungle
58% employee growth in 12 months
Aug 2024
$47m
SERIES C
Nov 2023
$22m
LATE VC
Cambridge, UK
Dr Tim Guilliams
(CEO)Previously worked as a Junior Associate Fellow at the Centre for Science and Policy. Is Founding Director and Trustee of Cambridge Rare Disease Network, and an Entrepreneurship Fellow at Cambridge Judge Business School.
David Brown
(Chairman)Previously served as Managing Director of Alchemy Biomedical Consulting. Is Chair of the Board at ProFactor Pharma and Babraham Institute Enterprise.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job
